Aurobindo Pharma consolidated net profit declines 9.66% in the December 2024 quarter
Net profit of Aurobindo Pharma declined 9.66% to Rs 845.81 crore in the quarter ended December 2024 as against Rs 936.29 crore during the previous quarter ended December 2023. Sales rose 8.55% to Rs 7893.15 crore in the quarter ended December 2024 as against Rs 7271.23 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 7893.15 | 7271.23 | 9 |
| OPM % | 19.99 | 21.99 | - |
| PBDT | 1618.38 | 1685.69 | -4 |
| PBT | 1199.85 | 1262.42 | -5 |
| NP | 845.81 | 936.29 | -10 |
